中文 | English
Return
Total: 215 , 1/22
Show Home Prev Next End page: GO
Author:( Mei GENG)

1. A retrospective analysis of combined chemoradiotherapy for locally advanced esophageal carcinoma

Mei GENG

Tumor 2008;28(11):972-975

2.THE THERAPEUTIC EFFECT OF MONOCLONAL ANTI EGFR ANTIBODY LEADING CHEMOTHERAPY TO HUMAN TUMOR

Guyin LOU ; Mei GENG ; Jinsong JIANG ;

Cancer Research and Clinic 2001;0(02):-

4.Analysis on Government Health Investment Process in Shanxi:an example of central special funds

Yunxia ZHANG ; Mei LI ; Jing YUAN ; Xinli GENG

Chinese Health Economics 2013;(11):49-50

5.Upper Limb Movement Deficiency in Children with Autism and Related Factors

Mei WANG ; Di GENG ; Yanping YANG ; Wenyan WANG

Chinese Journal of Rehabilitation Theory and Practice 2016;22(2):207-211

6.Studies on sLe~(a/x) and Hematogenous Metastasis of Cancer

Yun-Li PENG ; Jing LI ; Mei-Yu GENG ;

China Biotechnology 2006;0(06):-

7.Malignancy with immune thrombocytopenia

Fenqin ZHANG ; Mei GENG ; Wenqi XI ; Al ET

China Oncology 2001;0(02):-

8.SCHWABE Company's patent portfolio of Ginkgo biloba preparation.

Wei LIU ; Xin-Min CHENG ; Dong-Mei GENG ; Wei TAN ; Wen-Jun ZOU

China Journal of Chinese Materia Medica 2014;39(17):3384-3388

9.Effect of sulfated polymannuroguluronate on Tat induced proinflammatory cytokines release in THP-1 cells and its mechanism of action.

Bin HUI ; Mei-yu GENG ; Jing LI

Acta Pharmaceutica Sinica 2006;41(4):338-341

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 215 , 1/22 Show Home Prev Next End page: GO